in this issue
EnviroTech :: Biotech
Abbott Completes Acquisition of Facet Biotech
10:18 PM MDT | April 21, 2010 | Deepti Ramesh
Abbott Laboratories (Abbott Park, IL) says it has completed the previously announced acquisition of biotechnology company Facet Biotech (Redwood City, CA), for a total transaction value of about $450 million. The acquisition provides Abbott with a promising biologic intended to treat multiple sclerosis and compounds that complement its existing diverse oncology program. “Facet's depth of biologics experience and sophisticated antibody engineering platforms complement Abbott's current R&D programs in oncology, immunology and other therapeutic...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee